ArticleXenotransplantation
Removal of Porcine Endogenous Retroviruses in Decellularized Liver Bioscaffolds.
Article in Xenotransplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Xenotransplantation Literature Update: January-June 2026.XenotransplantationReview
- Article
- Xenotransplantation Literature Update: July-December 2025.XenotransplantationReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Tissue engineering using decellularized liver scaffolds presents a promising approach in regenerative medicine, offering a potential alternative to donor organ transplantation. The use of human livers as a bioscaffold is restricted by their limited availability and quality. Porcine livers offer an alternative due to their anatomical and physiological similarities to human livers. However, applying porcine-derived biomaterials in a clinical setting poses a risk of pathogen transmission, which is a noteworthy concern. Porcine endogenous retroviruses (PERVs), which are integrated into the genome of all pig breeds, are of particular concern, as subclasses PERV-A and PERV-B have shown to infect human cells in vitro. It is therefore essential to effectively remove all PERVs when manufacturing porcine scaffolds. In this study, we assessed the presence of PERV-specific DNA, RNA, and protein in decellularized porcine livers. Our findings prove that genetic and protein PERV material was effectively removed from porcine livers during our decellularization procedure. This finding substantiates the potential of using decellularized scaffolds of porcine origin for clinical applications without risk of PERV transmission.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.